Table 5
The results of the analysis of fluorescein angiograms at baseline and after treatment
| Brinzolamide | Placebo | |||
|---|---|---|---|---|
| Baseline | Drug | Baseline | Placebo | |
| Brinzolamide therapy alone resulted in a significant shortening of AVP, while peripapillary retinal vessels diameters remained unaffected | ||||
| *p<0.05 (Bonferroni-Dunn). | ||||
| AVP (s) | 1.64 (0.43) | 1.46 (0.39)* | 1.59 (0.47) | 1.7 (0.35) |
| Retinal arterial diameter (μm) | 103.2 (13.8) | 102.6 (12.7) | 106.1 (13.4) | 101.9 (10.4) |
| Retinal vein diameter (μm) | 139.3 (15.2) | 138.3 (16.3) | 136.2 (13.8) | 136.9 (13.0) |
